The study targets patients with refractory, unresectable microsatellite-stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC)
ILUMYA has already earned FDA approvals for scalp and nail plaque psoriasis in April 2024 and December 2025
At the center of the announcement are two late-breaking studies that could reshape treatment approaches for patients with high cholesterol and a complex form of heart failure
The expansion builds on Veristat’s work helping Chinese pharmaceutical firms such as Hansoh Pharma and CStone Pharmaceuticals
Pivya is Alembic’s first branded pharmaceutica product in the US and is being marketed through Alembic Therapeutics LLC
The decision marks a pivotal moment for the Massachusetts-based biotech giant
The order will cover the manufacturing of bulk vaccine in 2026
The therapy, also known as UM171 Cell Therapy, recently received conditional marketing authorization from the European Commission
The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability
mNEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe
Subscribe To Our Newsletter & Stay Updated
